Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Masferrer

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Cyclooxygenase-2 is overexpressed in human cervical cancerS Kulkarni, J S Rader, F Zhang, et al.
Experimental Eye Research|April 1, 1991
12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the corneaJ L Masferrer, J A Rimarachin, M E Gerritsen, et al.
The Journal of Clinical Investigation|July 1, 1995
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitorsD Salvemini, P T Manning, B S Zweifel, et al.
The Journal of Experimental Medicine|September 1, 1996
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivoJ P Portanova, Y Zhang, G D Anderson, et al.
American Journal of Obstetrics and Gynecology|February 29, 2000
Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2Y Sadovsky, D M Nelson, L J Muglia, et al.
Gastroenterology|April 30, 1999
Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascitesM Bosch-Marcè, J Clària, E Titos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenicJ L Masferrer, B S Zweifel, P T Manning, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancersA T Koki, N K Khan, B M Woerner, et al.
The Journal of Biological Chemistry|November 15, 1988
12(R)-hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from the bovine corneal epitheliumR C Murphy, J R Falck, S Lumin, et al.
Nitric Oxide : Biology and Chemistry|June 4, 2018
Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potentialE S Buys, D P Zimmer, J Chickering, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Cyclooxygenase-2 is overexpressed in human cervical cancerS Kulkarni, J S Rader, F Zhang, et al.
Experimental Eye Research|April 1, 1991
12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the corneaJ L Masferrer, J A Rimarachin, M E Gerritsen, et al.
The Journal of Clinical Investigation|July 1, 1995
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitorsD Salvemini, P T Manning, B S Zweifel, et al.
The Journal of Experimental Medicine|September 1, 1996
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivoJ P Portanova, Y Zhang, G D Anderson, et al.
American Journal of Obstetrics and Gynecology|February 29, 2000
Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2Y Sadovsky, D M Nelson, L J Muglia, et al.
Gastroenterology|April 30, 1999
Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascitesM Bosch-Marcè, J Clària, E Titos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenicJ L Masferrer, B S Zweifel, P T Manning, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancersA T Koki, N K Khan, B M Woerner, et al.
The Journal of Biological Chemistry|November 15, 1988
12(R)-hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from the bovine corneal epitheliumR C Murphy, J R Falck, S Lumin, et al.
Nitric Oxide : Biology and Chemistry|June 4, 2018
Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potentialE S Buys, D P Zimmer, J Chickering, et al.
Pageof 6